More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions attributed to its $3 billion cost-cutting plan announced last July.

More biopharma layoffs are hitting New Jersey, this time from Merck & Co.in the latest phase of headcount reductions attributed to its $3 billion cost-cutting plan announced last…

Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government healthcare initiative, representatives for the companies told…